X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4079) 4079
Patent (536) 536
Publication (367) 367
Book Review (249) 249
Newspaper Article (227) 227
Conference Proceeding (188) 188
Book Chapter (54) 54
Magazine Article (45) 45
Book / eBook (42) 42
Report (23) 23
Web Resource (18) 18
Dissertation (14) 14
Government Document (11) 11
Reference (6) 6
Trade Publication Article (6) 6
Music Score (5) 5
Newsletter (3) 3
Data Set (2) 2
Paper (2) 2
Streaming Audio (2) 2
Archival Material (1) 1
Pamphlet (1) 1
Streaming Video (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1180) 1180
index medicus (790) 790
female (689) 689
male (550) 550
animals (461) 461
adult (366) 366
middle aged (324) 324
research (264) 264
aged (247) 247
analysis (237) 237
chemistry (235) 235
metallurgy (207) 207
electricity (195) 195
article (177) 177
oncology (174) 174
mice (159) 159
infectious diseases (143) 143
adolescent (138) 138
organic chemistry (136) 136
immunology (130) 130
risk factors (129) 129
health aspects (125) 125
biochemistry & molecular biology (119) 119
studies (117) 117
cell biology (113) 113
prevention (113) 113
chemical surface treatment (109) 109
coating by vacuum evaporation, by sputtering, by ion implantationor by chemical vapour deposition, in general (109) 109
coating by vacuum evaporation, by sputtering, by ionimplantation or by chemical vapour deposition, in general (109) 109
coating material with metallic material (109) 109
coating metallic material (109) 109
diffusion treatment of metallic material (109) 109
inhibiting corrosion of metallic material or incrustation ingeneral (109) 109
microbiology (109) 109
surface treatment of metallic material by diffusion into thesurface, by chemical conversion or substitution (109) 109
expression (108) 108
human necessities (108) 108
cancer (107) 107
united states (107) 107
proteins (106) 106
young adult (106) 106
research article (103) 103
hiv (100) 100
multidisciplinary sciences (98) 98
hygiene (97) 97
neurosciences (97) 97
medical or veterinary science (96) 96
pharmacology & pharmacy (96) 96
medicine, general & internal (95) 95
basic electric elements (94) 94
women (94) 94
performing operations (93) 93
transporting (93) 93
risk (92) 92
usage (91) 91
management (86) 86
physics (86) 86
veterinary sciences (86) 86
literature (85) 85
general tagging of cross-sectional technologies spanning over several sections of the ipc (84) 84
general tagging of new technological developments (84) 84
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (84) 84
clinical trials (83) 83
physiological aspects (83) 83
surgery (83) 83
medieval & renaissance studies (80) 80
clinical neurology (76) 76
pregnancy (75) 75
abridged index medicus (74) 74
care and treatment (74) 74
heterocyclic compounds (74) 74
methods (74) 74
molecular sequence data (74) 74
time factors (74) 74
neoplasm invasiveness (73) 73
tenofovir (73) 73
biology (72) 72
human immunodeficiency virus--hiv (72) 72
preparations for medical, dental, or toilet purposes (72) 72
infection (70) 70
treatment outcome (70) 70
pharmacokinetics (69) 69
hiv infections - prevention & control (67) 67
aged, 80 and over (66) 66
child (66) 66
medicine & public health (66) 66
melanoma - pathology (66) 66
prospective studies (66) 66
rats (66) 66
history (65) 65
specific therapeutic activity of chemical compounds ormedicinal preparations (65) 65
retrospective studies (64) 64
semiconductor devices (64) 64
electric solid state devices not otherwise provided for (63) 63
growth (63) 63
medical research (63) 63
melanoma (63) 63
ecology (61) 61
public health (61) 61
tumor cells, cultured (61) 61
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (11) 11
Robarts - Stacks (11) 11
UofT at Mississauga - Stacks (11) 11
Gerstein Science - Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Victoria University Emmanuel College - Stacks (6) 6
Music - Stacks (5) 5
Knox College (Caven) - Stacks (4) 4
UofT at Scarborough - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
St. Augustine's Seminary - Stacks (3) 3
St. Michael's College (John M. Kelly) - 3rd Floor (3) 3
Trinity College (John W Graham) - Stacks (3) 3
Engineering & Comp. Sci. - Stacks (2) 2
Mathematical Sciences - Stacks (2) 2
Regis College - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Victoria University Emmanuel College - Birge Storage (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Criminology - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Knox College (Caven) - Reference (1) 1
Map & Data - Map Collection (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Royal Ontario Museum - Periodical Stacks (1) 1
UofT Schools - Special Collections (1) 1
Victoria University CRRS - Library use only (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5137) 5137
French (407) 407
German (95) 95
Chinese (33) 33
Dutch (14) 14
Spanish (13) 13
Portuguese (9) 9
Korean (8) 8
Japanese (4) 4
Danish (3) 3
Italian (2) 2
Norwegian (2) 2
Arabic (1) 1
Czech (1) 1
Estonian (1) 1
Hungarian (1) 1
Latin (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 16, pp. 1527 - 1539
Journal Article
by Allemani, Claudia and Matsuda, Tomohiro and Di Carlo, Veronica and Harewood, Rhea and Bonaventure, Audrey and Valkov, Mikhail and Estève, Jacques and Azevedo e Silva, Gulnar and Chen, Wan-Qing and Eser, Sultan and Engholm, Gerda and Stiller, Charles A and Monnereau, Alain and Woods, Ryan R and Lim, Gek Hsiang and Aitken, Joanne and Coleman, Michel P and Hamdi-Chérif, M and Zaidi, Z and Regagba, D and Bayo, S and Cheick Bougadari, T and Manraj, S S and Fabowale, A and Bradshaw, D and Somdyala, N I M and Kumcher, I and Moreno, F and Calabrano, G H and Espinola, S B and Fita, R and Diumenjo, M C and Ibañez, S G and De Souza, P C F and Del Pino, K and Laporte, C and Curado, M P and de Oliveira, J C and Veneziano, C L A and Veneziano, D B and Rebelo, M S and Santos, M O and Galaz, J C and Aparicio Aravena, M and Sanhueza Monsalve, J and Vargas, S and Herrera, V M and Uribe, C J and Bravo, L E and Garcia, L S and Arias-Ortiz, N E and Morantes, D and Jurado, D M and Yépez Chamorro, M C and Delgado, S and Ramirez, M and Martínez-Reyes, F and Quinto, R and Castillo, J and Mendoza, M and Cueva, P and Deloumeaux, J and Joachim, C and Macni, J and Carrillo, R and Shalkow Klincovstein, J and Rivera Gomez, R and Tortolero-Luna, G and Zavala, D and Alonso, R and Barrios, E and Eckstrand, A and Nikiforuk, C and Noonan, G and Turner, D and Kumar, E and Zhang, B and McCrate, F R and Ryan, S and MacIntyre, M and Saint-Jacques, N and Nishri, D E and McClure, C A and Vriends, K A and Kozie, S and Freeman, T and George, J T and Brockhouse, J T and O'Brien, D K and Holt, A and Almon, L and Kwong, S and Morris, C and Rycroft, R and Mueller, L and Phillips, C E and Brown, H and Cromartie, B and Schwartz, A G and Vigneau, F and ... and CONCORD Working Group and CONCORD Working Grp and Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
The Lancet, ISSN 0140-6736, 03/2018, Volume 391, Issue 10125, pp. 1023 - 1075
Journal Article
2008, 1st ed., ISBN 008045089X, xxiii, 662
The book brings together research that investigates how people experience products: durable, non-durable, or virtual. In contrast to other books, the present... 
Brand choice | Design | Psychological aspects | Consumer behavior | Consumers' preferences | Human factors | Psychology | New products
Book
The New England Journal of Medicine, ISSN 0028-4793, 11/2004, Volume 351, Issue 20, pp. 2058 - 2068
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 4, pp. 347 - 357
In a randomized trial of patients with type 2 diabetes, treatment with dapagliflozin, an SGLT2 inhibitor that promotes glucosuria, did not result in a higher... 
2013 ACCF/AHA GUIDELINE | MEDICINE, GENERAL & INTERNAL | SELECTIVE SGLT2 INHIBITOR | MANAGEMENT | HEART-FAILURE OUTCOMES | DISEASE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | KIDNEY | EMPAGLIFLOZIN | SOCIETY | Cardiovascular Diseases - etiology | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Benzhydryl Compounds - therapeutic use | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Type 2 diabetes | Safety and security measures | Dapagliflozin | Dosage and administration | Drug therapy | Cardiovascular diseases | Risk factors | Heart failure | Myocardial infarction | Cerebral infarction | End-stage renal disease | Heart attacks | Mortality | Diabetes mellitus | Cardiovascular disease | FDA approval | Patients | Glomerular filtration rate | Heart rate | Ischemia | Sodium | Arteriosclerosis | Ketoacidosis | Death | Diabetes | Kidney diseases | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Life Sciences | Food and Nutrition | Animal biology | Cellular Biology | Pharmaceutical sciences | Cardiovascular Diseases | drug therapy | Benzhydryl Compounds | complications | Sodium-Glucose Transporter 2 Inhibitors | Hospitalization | prevention & control | Klinisk medicin | Diabetes Mellitus | etiology | Clinical Medicine | epidemiology | statistics & numerical data | adverse effects | mortality | Type 2 | Heart Failure | therapeutic use | Glucosides
Journal Article